美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

SPDR S&P Biotech ETF

162.38

-5.8500-3.48%

盘后：162.500.1200+0.07%19:59 EDT

成交量：979.48万

成交额：16.03亿

市值：115.82亿

市盈率：8.91

高：167.12

开：166.72

低：162.16

收：168.23

52周最高：169.89

52周最低：89.33

股本：7,132.50万

流通股本：7,132.50万

量比：1.17

换手率：13.73%

股息：0.57

股息率：0.35%

每股收益(TTM):18.23

净资产收益率：--

总资产收益率：--

市净率：--

市盈率(LYR):- -

数据加载中...

总览公司新闻公告

医药基金净值大幅攀升机构配置尚处历史低位

枪杀美国联合健康保险CEO的曼吉奥内就联邦指控认罪

路易吉，正式认罪！他此前当街枪杀美国联合健康保险CEO，或面临终身监禁

每日经济新闻

路易吉，正式认罪！他此前当街枪杀美国联合健康保险CEO，或面临终身监禁

每日经济新闻

路易吉・曼乔内在法庭上承认，他枪击了联合健康保险原首席执行官布莱恩・汤普森。

惠誉：随着医疗保险和社会保障支出到 2032 年将接近增加 1 个百分点的国内生产总值，财政压力将会加剧。

“人才版图”引领绘就生物医药千亿“产业蓝图”

经济参考报

医疗保健板块快讯：市场动态综述

医疗保健板块综述：市场快讯

上海：完善上海市重点产业地图，聚焦集成电路、生物医药、人工智能三大先导产业

民祥生物医药被出具警示函，涉未披露年报等

花旗(C.US)调整北美医疗健康投行团队强化医疗赛道核心竞争力

辰欣药业等成立生物科技公司

生物医药赛道迎来机构扎堆调研商业化与全球化进展成关注重点

人工智能公司Anthropic已告知部分投资者，该公司计划进一步拓展医疗保健与生物学领域业务。

医疗板块综述：市场快评

医疗保健板块动态：市场速评

新闻稿：Ernexa Therapeutics 引入资深生物技术高管 David Polinsky 加入董事会，为临床阶段冲刺蓄力

医疗保健板块市场动态速览

港股生物医药股盘初走高，药明康德股价突破200港元关口创历史新高

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/stock/XBI/news?page=5"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"XBI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","market":"US","secType":"STK","nameCN":"SPDR S&P Biotech ETF","latestPrice":162.38,"timestamp":1787947200000,"preClose":168.23,"halted":0,"volume":9794803,"hourTrading":{"tag":"盘后","latestPrice":162.5,"preClose":162.38,"latestTime":"19:59 EDT","volume":351871,"amount":57155049.2883,"timestamp":1787961580282,"change":0.12,"changeRate":0.000739,"amplitude":0.002291},"delay":0,"changeRate":-0.034773821553825086,"floatShares":71325000,"shares":71325000,"eps":18.23,"marketStatus":"休市中","change":-5.85,"latestTime":"08-28 16:00:00 EDT","open":166.72,"high":167.12,"low":162.16,"amount":1602908344.8745801,"amplitude":0.029483,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":18.23,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1788163200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":168.23,"sharesOutstanding":63325000,"nav":168.226452,"aum":11927255445.27,"dividendRate":0.003526,"bidAskSpread":0.000332,"preHourTrading":{"tag":"盘前","latestPrice":166.64,"preClose":168.23,"latestTime":"09:29 EDT","volume":15164,"amount":2537841.88424,"timestamp":1787923799999,"change":-1.59,"changeRate":-0.009451,"amplitude":0.013672},"postHourTrading":{"tag":"盘后","latestPrice":162.5,"preClose":162.38,"latestTime":"19:59 EDT","volume":351871,"amount":57155049.2883,"timestamp":1787961580282,"change":0.12,"changeRate":0.000739,"amplitude":0.002291},"volumeRatio":1.168677305334014,"optionData":{"bulkOrders":[{"symbol":"XBI","call":true,"expireDate":1797570000000,"strike":"180.0","timestamp":1787936069389,"price":5.97,"volume":3000,"amount":1791000,"type":"+"}]},"impliedVol":0.3111,"impliedVolPercentile":0.5378},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","floatShares":71325000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.168677305334014,"shares":71325000,"dividePrice":0.5725,"high":167.12,"amplitude":0.029483,"preClose":168.23,"low":162.16,"week52Low":89.33,"pbRate":"--","week52High":169.89,"institutionHeld":0.8511,"latestPrice":162.38,"eps":18.23,"divideRate":0.003526,"volume":9794803,"delay":0,"ttmEps":18.23,"open":166.72,"prevYearClose":121.93,"prevWeekClose":165.73,"prevMonthClose":147.01,"prevQuarterClose":158.25,"fiveDayClose":165.73,"twentyDayClose":147.01,"sixtyDayClose":129.83},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XBI\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"XBI","amount":0.138094,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-24","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-24"},{"date":"2025-12-22","symbol":"XBI","amount":0.406564,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-24"},{"date":"2025-09-22","symbol":"XBI","amount":0.02665,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-24","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-24"},{"date":"2025-06-23","symbol":"XBI","amount":0.007295,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-25","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-25"},{"date":"2025-03-24","symbol":"XBI","amount":0.00525,"announcedDate":"2025-03-21","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-24","defaultRemindTime":1742823000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-26","payableDate":"2025-03-24","currency":"USD","dateTimestamp":1742788800000,"payDate":"2025-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XBI\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-26","value":0.031139,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-27","value":0.01831,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-27","value":0.019702,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-26","value":0.110135,"currency":"USD"},{"executeDate":"2017-09-15","recordDate":"2017-09-18","paymentDate":"2017-09-25","value":0.03704,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XBI\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XBI\",pageSize:20,pageCount:5,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660108069","title":"医药基金净值大幅攀升 机构配置尚处历史低位","url":"https://stock-news.laohu8.com/highlight/detail?id=2660108069","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660108069?lang=zh_cn&edition=fundamental","pubTime":"2026-08-17 06:17","pubTimestamp":1786918664,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4550","XBI","XLV","BK4585","BK4581","BK4588","LABU","VHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659131127","title":"枪杀美国联合健康保险CEO的曼吉奥内就联邦指控认罪","url":"https://stock-news.laohu8.com/highlight/detail?id=2659131127","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659131127?lang=zh_cn&edition=fundamental","pubTime":"2026-08-15 09:50","pubTimestamp":1786758600,"startTime":"0","endTime":"0","summary":"据CCTV国际时讯消息，8月14日，被控枪杀美国联合健康保险公司首席执行官布赖恩·汤普森（BrianThompson）的路易吉·曼吉奥内在法庭上表示，他就其联邦刑事案件认罪，承认自己枪杀了汤普森。这一认罪协议将避免这起备受瞩目的案件进入联邦审判阶段。此外，认罪还可能使曼吉奥内得以寻求撤销纽约州的谋杀指控，并推迟即将到来的州审判。曼吉奥内目前面临联邦指控和州指控。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608153842363652.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608153842363652.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4581","LABU","XBI","BK4588","BK4585","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659552127","title":"路易吉，正式认罪！他此前当街枪杀美国联合健康保险CEO，或面临终身监禁","url":"https://stock-news.laohu8.com/highlight/detail?id=2659552127","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659552127?lang=zh_cn&edition=fundamental","pubTime":"2026-08-15 08:22","pubTimestamp":1786753353,"startTime":"0","endTime":"0","summary":"当地时间8月14日，路易吉·曼吉奥内就枪杀联合健康保险首席执行官布赖恩·汤普森（BrianThompson）一案正式认罪。联邦法官将路易吉·曼吉奥内的量刑日期定于12月18日。路易吉·曼吉奥内当天在法庭上表示，他就其联邦刑事案件认罪，承认自己枪杀了汤普森。这一认罪协议将避免这起备受瞩目的案件进入联邦审判阶段。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608153842343196.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608153842343196.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4588","LABU","XLV","BK4581","BK4585","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659276311","title":"路易吉，正式认罪！他此前当街枪杀美国联合健康保险CEO，或面临终身监禁","url":"https://stock-news.laohu8.com/highlight/detail?id=2659276311","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659276311?lang=zh_cn&edition=fundamental","pubTime":"2026-08-15 08:22","pubTimestamp":1786753320,"startTime":"0","endTime":"0","summary":"路易吉·曼吉奥内当天在法庭上表示，他就其联邦刑事案件认罪，承认自己枪杀了汤普森。此外，认罪还可能使曼吉奥内得以寻求撤销纽约州的谋杀指控，并推迟即将到来的州审判。曼吉奥内目前面临联邦指控和州指控。州级指控方面，曼吉奥内此前面临二级谋杀、非法持有武器、持有虚假身份证明等多项罪名指控。如果二级谋杀罪名成立，曼吉奥内将面临25年至终身监禁的刑罚。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2026-08-15/doc-ininiyys3677355.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-08-15/doc-ininiyys3677355.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4581","XBI","BK4585","XLV","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659128599","title":"路易吉・曼乔内在法庭上承认，他枪击了联合健康保险原首席执行官布莱恩・汤普森。","url":"https://stock-news.laohu8.com/highlight/detail?id=2659128599","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659128599?lang=zh_cn&edition=fundamental","pubTime":"2026-08-14 23:40","pubTimestamp":1786722026,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["XLV","XBI","BK4588","BK4585","BK4581","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659167007","title":"惠誉： 随着医疗保险和社会保障支出到 2032 年将接近增加 1 个百分点的国内生产总值，财政压力将会加剧。","url":"https://stock-news.laohu8.com/highlight/detail?id=2659167007","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659167007?lang=zh_cn&edition=fundamental","pubTime":"2026-08-14 04:39","pubTimestamp":1786653589,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LABU","BK4581","XLV","BK4588","XBI","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659164273","title":"“人才版图”引领 绘就生物医药千亿“产业蓝图”","url":"https://stock-news.laohu8.com/highlight/detail?id=2659164273","media":"经济参考报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659164273?lang=zh_cn&edition=fundamental","pubTime":"2026-08-14 03:50","pubTimestamp":1786650640,"startTime":"0","endTime":"0","summary":"研发出首个幽门螺杆菌创新药的丹诺医药成功登陆香港联交所，用于治疗胃癌的1类创新药安尼妥单抗注射液正式获批上市，精神分裂症治疗创新药凯捷乐从苏州首发销往全国……今年以来，苏州工业园区生物医药板块“捷报”频传。生物医药创新成果竞相涌现的背后，离不开引领产业发展的人才支撑。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608143840851846.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608143840851846.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4585","399441","161726","BK4588","XBI","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141376784","title":"医疗保健板块快讯：市场动态综述","url":"https://stock-news.laohu8.com/highlight/detail?id=1141376784","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141376784?lang=zh_cn&edition=fundamental","pubTime":"2026-08-14 00:24","pubTimestamp":1786638273,"startTime":"0","endTime":"0","summary":"医疗保健行业最新市场动态速览。该报道内容精选自专题市场快讯。该协会援引内部调查数据称，从去年1月到今年6月，Interpharma的成员企业，在总共22款新药中，有7款拒绝向瑞士医保机构提交报销申请。Interpharma表示，为了不危及美国市场的定价，药企往往会搁置其研发的新药，平均每三款就有一款暂停提交申请。KPJ Healthcare第二季度核心净利润预计将环比走强。该股目前股价持平，报3.07林吉特。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LABU","BK4588","XLV","XBI","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161156613","title":"医疗保健板块综述：市场快讯","url":"https://stock-news.laohu8.com/highlight/detail?id=1161156613","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161156613?lang=zh_cn&edition=fundamental","pubTime":"2026-08-13 16:24","pubTimestamp":1786609477,"startTime":"0","endTime":"0","summary":"以下为最新医疗保健板块市场快讯，内容涵盖亚太及北美市场动态。RHB维持对KPJ的“买入”评级，目标股价定为3.77林吉特。Apotex公司在公开市场首秀中，其美国业务部门成为明显的软肋。该丹麦制药商的CEO似乎对减肥药丸市场的前景非常乐观，但贝伦贝格认为，诺和诺德可能需要通过交易来增加更多的口服药物，以维持其领先地位。贝伦贝格将诺和诺德股票的评级从“买入”下调至“持有”，并将目标价从325丹麦克朗下调至305丹麦克朗。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","XBI","LABU","BK4585","BK4588","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659182162","title":"上海：完善上海市重点产业地图，聚焦集成电路、生物医药、人工智能三大先导产业","url":"https://stock-news.laohu8.com/highlight/detail?id=2659182162","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659182162?lang=zh_cn&edition=fundamental","pubTime":"2026-08-13 10:14","pubTimestamp":1786587282,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["XBI","QMAR","DQJN","KOMP","QID","QQQM","CPNQ","PSQ","NJUL","QSWN","AIFD","AIBU","TQQQ","MVPS","PBOT","09086","03086","AQGX","QQQ","CHAT","LCLG","NAPR","CWC","AGIX","AIQU","GPIQ","QQA","TARK","GK","ARTY","03034","NOCT","MFIG","07266","TECY","FWD","NBDS","NJAN","WPAI","OGIG","QDEC","NEWZ","TQQY","VUSE","03455","QTOC","QLD","QQQX","09834","SQQQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658974771","title":"民祥生物医药被出具警示函，涉未披露年报等","url":"https://stock-news.laohu8.com/highlight/detail?id=2658974771","media":"蓝鲸财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658974771?lang=zh_cn&edition=fundamental","pubTime":"2026-08-12 19:44","pubTimestamp":1786535098,"startTime":"0","endTime":"0","summary":"蓝鲸新闻8月12日讯，近日，天津证监局发布行政监管措施决定书，剑指天津民祥生物医药股份有限公司及相关责任人。决定书显示，民祥医药存在以下情形：未按规定披露2025年年度报告，补充披露相关人事及股东会决议公告不及时，为子公司提供担保未履行审议程序及信息披露义务。以上行为违反了《非上市公众公司监督管理办法》和《非上市公众公司信息披露管理办法》的相关规定。公司董事长刘万里、副总经理兼董秘张毅对上述违规事项负有责任。针对上述违法行为，天津证监局对民祥医药、刘万里、张毅采取出具警示函的监督管理措施，记入证券期货市场诚信档案。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1786526206112430419","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK4585","BK4588","399441","XBI","161726","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658921870","title":"花旗(C.US)调整北美医疗健康投行团队 强化医疗赛道核心竞争力","url":"https://stock-news.laohu8.com/highlight/detail?id=2658921870","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658921870?lang=zh_cn&edition=fundamental","pubTime":"2026-08-12 14:25","pubTimestamp":1786515916,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，花旗集团近日为医疗健康投行业务线新任命多名主管，计划借此提升行业地位，在火热的医疗赛道强化核心竞争力。全球医疗健康投行主管Sumit Khedekar发布内部备忘录称，本次调整敲定了北美地区生物科技、医疗器械、生物制药等多个医疗细分领域新任负责人人选。花旗银行业务主管Vis Raghavan今年5月在投资者大会上明确指出，医疗健康与科技、工业板块并列为三大高增长赛道，是花旗投行团队的重点攻坚方向。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1478890.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2417539215.USD","159760","LABU","BK4504","LU2456880835.USD","XBI","LU0128525689.USD","LU0162691827.USD","LU2236285917.USD","BK4581","BK4588","LU1366192091.USD","LU0203347892.USD","LU0106831901.USD","LU1244550577.SGD","BK4559","LU0072461881.USD","LU2360032135.SGD","BK4585","LU0310800965.SGD","LU1074936037.SGD","LU1244550221.USD","LU1791807156.HKD","LU0320765646.SGD","LU1668664300.SGD","LU1267930227.SGD","LU0052756011.USD","LU0130517989.USD","LU0170899867.USD","LU2125154935.USD","VHT","LU0980610538.SGD","XLV","IXJ","FTXO","IYF","BK4566","LU1506573853.SGD","BK4207","LU1201861249.SGD","LU0648001328.SGD","LU0203345920.USD","LU0314106906.USD","LU0130102774.USD","LU1162221912.USD","159891","TFNS","BK4550","LU0098860793.USD","LU2462157665.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658092329","title":"辰欣药业等成立生物科技公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2658092329","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658092329?lang=zh_cn&edition=fundamental","pubTime":"2026-08-12 12:37","pubTimestamp":1786509464,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["AGNG","BK4581","BK4588","XBI","IEIH","BK4585","MEDX","GDOC","SYNB","IBBJ","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658941844","title":"生物医药赛道迎来机构扎堆调研 商业化与全球化进展成关注重点","url":"https://stock-news.laohu8.com/highlight/detail?id=2658941844","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658941844?lang=zh_cn&edition=fundamental","pubTime":"2026-08-12 07:02","pubTimestamp":1786489344,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","BK4581","BK4588","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658963570","title":"人工智能公司Anthropic已告知部分投资者，该公司计划进一步拓展医疗保健与生物学领域业务。","url":"https://stock-news.laohu8.com/highlight/detail?id=2658963570","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658963570?lang=zh_cn&edition=fundamental","pubTime":"2026-08-11 09:02","pubTimestamp":1786410136,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MFIG","WPAI","QQQ","NJAN","QQQX","AQGX","DQJN","NBDS","AIBU","GPIQ","CHAT","CPNQ","PSQ","AGIX","NOCT","FWD","QMAR","TARK","PBOT","KOMP","QQQM","VUSE","XBI","QTOC","CWC","NJUL","QDEC","QLD","QQA","VHT","AIFD","LABU","TQQQ","QID","CGVV","QSWN","AIQU","NOBL","TECY","XLV","MVPS","NEWZ","TQQY","LCLG","SQQQ","NAPR","OGIG","07568","GK","ARTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137780649","title":"医疗板块综述：市场快评","url":"https://stock-news.laohu8.com/highlight/detail?id=1137780649","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137780649?lang=zh_cn&edition=fundamental","pubTime":"2026-08-11 04:52","pubTimestamp":1786395164,"startTime":"0","endTime":"0","summary":"医疗板块最新市场快讯如约而至。本次快评内容聚焦于多家药企与医疗器械公司的动态，梳理了从晚期临床试验到财年业绩的各类关键信号。诺华股价当日微涨 0.3%。病理学服务提供商 Integral Diagnostics 的 2026 财年初步业绩，则令人失望。该公司预计年度营收在 7.88 亿至 7.90 亿澳元之间，低于市场普遍预期的 7.99 亿澳元。其运营息税折旧摊销前利润预计为 1.64 亿至 1.65 亿澳元，同样未能达到市场 1.69 亿澳元的预期。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LABU","XLV","BK4581","BK4585","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181671001","title":"医疗保健板块动态：市场速评","url":"https://stock-news.laohu8.com/highlight/detail?id=1181671001","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181671001?lang=zh_cn&edition=fundamental","pubTime":"2026-08-11 00:22","pubTimestamp":1786378967,"startTime":"0","endTime":"0","summary":"最新的一轮医疗保健板块市场速评已出炉，信息发布时间分别为美国东部时间凌晨4:20、中午12:20及下午4:50。0339 EDT - 诺华旗下降胆固醇新药pelacarsen，其一项晚期试验的成功概率，如今正悬念重重。摩根大通认为，该药物达到这一门槛的可能性仅有40%。该公司预计全年营收在7.88亿至7.90亿澳元之间，远低于市场普遍预期的7.99亿澳元。在本周初，该机构对该股维持“跑赢大盘”评级，目标价为每股2.85澳元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","LABU","XBI","BK4588","BK4585","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193258586","title":"新闻稿：Ernexa Therapeutics 引入资深生物技术高管 David Polinsky 加入董事会，为临床阶段冲刺蓄力","url":"https://stock-news.laohu8.com/highlight/detail?id=1193258586","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193258586?lang=zh_cn&edition=fundamental","pubTime":"2026-08-10 21:09","pubTimestamp":1786367399,"startTime":"0","endTime":"0","summary":"此次任命正值公司关键转折点，进一步强化了其领导团队——Ernexa 正全力推进其核心项目 ERNA-101，计划于2026年第三季度提交新药临床试验申请，并在第四季度启动首项一期临床研究。马萨诸塞州剑桥市，2026年8月10日——Ernexa Therapeutics，一家致力于开发创新细胞疗法以治疗晚期癌症和自身免疫性疾病的行业先锋，今日宣布任命 David Polinsky 为其董事会成员。“我们正步入 Ernexa 历史上最为重要的时期之一，”Ernexa Therapeutics 总裁兼首席执行官 Sanjeev Luther 表示。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","IND","BK4588","IBB","XBI","BK4233","BK4139","BK4007","BK4205","SYNB","BK4539","RFL","BBP","ERNA","LENZ","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124588838","title":"医疗保健板块市场动态速览","url":"https://stock-news.laohu8.com/highlight/detail?id=1124588838","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124588838?lang=zh_cn&edition=fundamental","pubTime":"2026-08-10 16:29","pubTimestamp":1786350589,"startTime":"0","endTime":"0","summary":"0729 GMT - 摩根大通分析师发布报告指出，诺华制药旗下降胆固醇药物pelacarsen的晚期试验前景尚不明朗。据摩根大通测算，这一结果发生的概率仅为40%。诺华股价微涨0.3%。该公司预计年度营收为7.88亿至7.90亿澳元，低于市场普遍预期的7.99亿澳元。其运营息税折旧摊销前利润预计为1.64亿至1.65亿澳元，也未达到市场预期的1.69亿澳元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","XLV","BK4581","LABU","XBI","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658609667","title":"港股生物医药股盘初走高，药明康德股价突破200港元关口创历史新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2658609667","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658609667?lang=zh_cn&edition=fundamental","pubTime":"2026-08-10 09:51","pubTimestamp":1786326707,"startTime":"0","endTime":"0","summary":"热点栏目自选股\n数据中心\n行情中心\n资金流向\n模拟交易客户端港股生物医药股盘初走高，药明康德一度涨超5%，股价突破200港元关口创历史新高，现涨超4%；再鼎医药涨超5%，诺诚建华、药明生物涨超3%。开源证券发布研报表示，投资上，我们建议重点关注减重代谢领域中口服司美格鲁肽及Foundayo两个确定性的增量机会。同时，药明康德小分子D&M 业务大体量下加速增长，预示着国内小分子CDMO 板块有望在未来3-5年迎来增长新周期，相关公司的签单收入有望逐步加速，利润端有望超预期增长。","market":"hk","thumbnail":"https://static.tigerbbs.com/25bb080e73b6be662c435ea6aeaec9c7","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/25bb080e73b6be662c435ea6aeaec9c7"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/2026-08-10/doc-inimuvrt8236475.shtml","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1997245094.SGD","IE00BPRC5H50.USD","LU0708995583.HKD","LU1303224171.USD","BK1141","KCAI","LU0052750758.USD","BK0216","LU2045819591.USD","XBI","LU1969619763.USD","LU1808992512.USD","IE00B543WZ88.USD","BK1583","LU0456842615.SGD","LU0348766576.USD","LU1770034418.SGD","LU2488822045.USD","EWH","LU1251922891.USD","LU1979443071.USD","VXUS","LU2242644610.SGD","LU2495084118.USD","LU1719994722.HKD","BK1576","09688","BK4581","LU1046422090.SGD","161726","IE00B5MMRT66.SGD","02359","LU0700851271.USD","LU1934453819.USD","LU0611395673.USD","LU2125910500.SGD","BK4585","BK4588","LU0320764599.SGD","LU1997244956.HKD","LU0348767384.USD","LU1997245177.USD","09969","LU2328871848.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":200,"code":"91000000","status":"200"}]}}